Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase I trial of carboplatin and weekly paclitaxel in patients with advanced non-small-cell lung cancer.

Phase I trial of carboplatin and weekly paclitaxel in patients with advanced non-small-cell lung cancer. Jpn J Clin Oncol. 2004 Sep; 34(9):505-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.